Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- King & Spalding
- Simpson Thacher & Bartlett LLP
- Blitman & King
- Crowell & Moring
- Stevens & Lee
- Burke Warren
- Porzio Bromberg
- Godfrey & Kahn
- Himes Petrarca
- BatesCarey
- Lowe Stein
- Terrell Hogan
- Skadden Arps
- Brown Rudnick
- Ballard Spahr
- Taft Stettinius
- Pashman Stein
- Gilbert LLP
- WilmerHale
- Davis Polk
- Arnold & Porter
- Miller Nash LLP
- ArentFox Schiff
- Jones Day
- Spangenberg Shibley
- Potter Anderson
- Porter Hedges
- Cleary Gottlieb
- Gage Spencer & Fleming
- Dentons
- Consovoy McCarthy
- Kirkland & Ellis
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- Joseph Hage
- ASK LLP
- Cuneo Gilbert
- WestLoop Law
- Phillips Lytle
- Slevin & Hart
- McGrail & Bensinger
- Bentley & Bruning
- Pachulski Stang
- Lerner Arnold
- Kramer Levin
- Bialson Bergen
- Bielli & Klauder
- ArentFox Schiff LLP
- Martin S. Rapaport
- Marino Tortorella
- Cronin Fried
- Lite DePalma
- Saul Ewing
- Wilk Auslander
- Stutzman Bromberg
- Brown & Connery
- Hagens Berman
- Keller Rohrback
- Napoli Shkolnik
- Robins Kaplan
- Marcus & Shapira
- Motley Rice
- Faegre Drinker
- Blank Rome
- Debevoise & Plimpton
- Mintz Levin
- Shafferman & Feldman
- Goodwin Procter
- Hughes Socol
- Reed Smith
- O'Melveny & Myers
- Kleinberg Kaplan
- Katsky Korins
- Clifford Law Offices
- Barack Ferrazzano
- Sherrard Roe
- Levenfeld Pearlstein
- Squire Patton
- Rothstein Mandell
- Doster Ullom
- MacElree Harvey
- Hurwitz Fine
- UB Greensfelder
- Keller Postman
- Pullman & Comley
- Loeb & Loeb
- Mehri & Skalet
- MoloLamken
- Shook Hardy
- Morgan Lewis
- Tarter Krinsky
- Tate Law Group LLC
- Klehr Harrison
- Frost Brown
- Lowey Dannenberg
- Williams Mullen
- Kobre & Kim
- Wachtell Lipton
- Waldrep Wall
- Dechert LLP
- Quinn Emanuel
- Ifrah Law
- Seward & Kissel
- Simmons Hanly
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- Duane Morris
- Troutman
- Pillsbury Winthrop
- O'Brien Belland
- Foley & Lardner
- Seyfarth Shaw
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Schulte Roth
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Nardello & Co. LLC
- CVS Health Corp.
- Impax Laboratories, Inc.
- Sandoz International GmbH
- Bausch Health Cos. Inc.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Omnicare Inc.
- Endo International PLC
- Province LLC
- United Parcel Service Inc.
- Avrio Health LP
- Express Scripts Holding Co.
- Hain Capital Group LLC
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Loblaw Cos.
- TR Capital Management LLC
- AXA XL Ltd.
- The Cigna Group
- Ironshore Inc.
- Noramco Inc.
- Blue Cross Blue Shield Association
- Alaska Native Tribal Health Consortium
- Walmart Inc.
- Viatris Inc.
- Anda Inc.
- AlixPartners LLP
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- FTI Consulting Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Tucson Medical Center
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Otis Worldwide Corp.
- DuPont de Nemours Inc.
- Cencora Inc.
- Old Republic Insurance Co.
- Oracle Corp.
- Giant Eagle Inc.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- McKesson Corp.
- Houlihan Lokey Inc.
- Johnson & Johnson
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Commonwealth of Massachusetts
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Pala Band of Mission Indians
- Town of Ramapo, New York
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Nez Perce Tribe
- Port Gamble S'Klallam Tribe
- State of Nevada
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- St. Regis Mohawk Tribe
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Hopi Tribe
- Tennessee Attorney General's Office
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
February 08, 2022
Canadian Entities Seek Late Appeal In Purdue Ch. 11 Case
Canadian entities are seeking permission to file a late appeal to a New York federal court ruling that vacated Purdue Pharma's Chapter 11 plan, saying Tuesday there are unresolved issues related to their claims that won't be covered by the drugmaker's challenge in the Second Circuit.
-
February 04, 2022
Purdue Asks For New Extension On Opioid Suit Freeze
Purdue Pharma has asked a New York bankruptcy judge for another extension on the opioid litigation injunction that has been in place since it filed for bankruptcy, citing word that a settlement agreement is near on a modified reorganization plan and the considerable work that would follow.
-
February 01, 2022
Purdue Closing In On New Ch. 11 Deal With Sackler Family
A New York bankruptcy judge extended a mediation deadline Tuesday in the Chapter 11 case of Purdue Pharma after the mediator reported the parties were close to a deal that would see members of the Sackler family significantly increase their more than $4.3 billion in payments under the debtor's scuttled plan.
-
January 03, 2022
A Blockbuster Year Ahead For Health, Life Sciences Litigation
Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
-
December 06, 2021
Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma
Members of the Sackler family who own drugmaker Purdue Pharma told a New York federal judge Monday that they did not increase transfers of cash out of the business in the run-up to its 2019 Chapter 11 filing, and instead left the company with more unrestricted cash than ever before at that time.
-
November 18, 2021
Purdue Cleared To Pay Gov't Groups Over $12M In Ch. 11 Fees
A New York bankruptcy judge approved a request from drugmaker Purdue Pharma LP to reimburse more than $12 million in fees incurred by groups representing government entities in its Chapter 11 plan mediation process, saying the groups made significant contributions to the confirmed plan.
-
November 09, 2021
Purdue Agrees Not To Finalize Ch. 11 Plan Until Appeals Done
A New York bankruptcy judge said Tuesday that a stay of the implementation of Purdue Pharma's Chapter 11 plan pending appeals was unnecessary after Purdue agreed not to take the plan's final steps until after the first round of appeals are decided.
-
October 25, 2021
Purdue Opposes Requests To Delay Ch. 11 Plan For Appeals
Purdue Pharma LP is arguing that delaying the consummation of its Chapter 11 plan to allow appeals to be resolved first would needlessly delay the distribution of billions of dollars for opioid abatement efforts while there was no danger of prejudice to the appellants.
-
October 20, 2021
Purdue Asks To Pay Ch. 11 Costs Of Government Committees
Bankrupt drugmaker Purdue Pharma LP asked for permission from a New York judge late Tuesday to pay $12.4 million in fees and expenses incurred by committees of nonconsenting state and local governments during a Chapter 11 plan mediation process.
-
October 14, 2021
Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away
A New York bankruptcy judge on Thursday denied a motion from parties appealing the confirmation of Purdue Pharma's Chapter 11 plan to bypass the normal appellate channels and bring their arguments directly to the Second Circuit.